Enfusion

Enfusion FCF/Debt

Delisted

The Free Cash Flow to Debt Ratio of Enfusion (ENFN) as of Nov 7, 2026 is -3.45 %. In the previous year, Free Cash Flow to Debt Ratio was 28.44 % — a change of -112.14% (lower).

FCF/Debt

-3.45 %

YoY

-112.14%

Last updated:

Free Cash Flow to Debt Ratio of Enfusion is 2020 -3.45 % . Free Cash Flow to Debt Ratio of Enfusion was 2019 28.44 % . It decreases by -112.14% lower compared to the previous year.

The Enfusion FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2019
28.44 USD
Jan 1, 2020
-3.45 USD
The Enfusion FCF/Debt history
YEARFCF/DebtYoY
-3.45 %-112.14%
28.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Free Cash Flow to Debt Ratio of Enfusion is -3.45 % in 2020.

Free Cash Flow to Debt Ratio of Enfusion changed from 28.44 % to -3.45 %, representing a -112.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Enfusion since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Enfusion

All Key Metrics — Enfusion